Ferlitsch A - Search Results

1

Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction.

Uschner FE, Glückert K, Paternostro R, Gnad T, Schierwagen R, Mandorfer M, Magdaleno F, Ortiz C, Schwarzkopf K, Kamath PS, Alessandria C, Boesecke C, Pfeifer A, Reiberger T, Kreisel W, Sauerbruch T, Ferlitsch A, Trebicka J, Klein S. Uschner FE, et al. Among authors: ferlitsch a. Liver Int. 2020 Sep;40(9):2228-2241. doi: 10.1111/liv.14586. Epub 2020 Jul 22. Liver Int. 2020. PMID: 32627946

2

Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.

Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M. Sieghart W, et al. Among authors: ferlitsch a. Dig Liver Dis. 2009 Dec;41(12):902-6. doi: 10.1016/j.dld.2009.04.013. Epub 2009 Jun 4. Dig Liver Dis. 2009. PMID: 19501032

3

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M. Reiberger T, et al. Among authors: ferlitsch a. J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15. J Viral Hepat. 2010. PMID: 19780945

4

Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.

Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Among authors: ferlitsch a. Clin Gastroenterol Hepatol. 2011 Jul;9(7):602-8.e1. doi: 10.1016/j.cgh.2011.03.002. Epub 2011 Mar 10. Clin Gastroenterol Hepatol. 2011. PMID: 21397726

5

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.

Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M. Pinter M, et al. Among authors: ferlitsch a. Aliment Pharmacol Ther. 2012 Jan;35(1):83-91. doi: 10.1111/j.1365-2036.2011.04896.x. Epub 2011 Oct 27. Aliment Pharmacol Ther. 2012. PMID: 22032637

6

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab. Reiberger T, et al. Among authors: ferlitsch a. J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15. J Gastroenterol. 2012. PMID: 22170417

7

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Ferlitsch M, et al. Among authors: ferlitsch a. Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22532296

8

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Among authors: ferlitsch a. Wien Klin Wochenschr. 2012 Jun;124(11-12):395-402. doi: 10.1007/s00508-012-0190-5. Epub 2012 Jun 15. Wien Klin Wochenschr. 2012. PMID: 22699260

9

A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.

Reiberger T, Payer BA, Ferlitsch A, Sieghart W, Breitenecker F, Aichelburg MC, Schmied B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab and Vienna HIV & Liver Study Group. Reiberger T, et al. Among authors: ferlitsch a. Antivir Ther. 2012;17(7):1327-34. doi: 10.3851/IMP2349. Epub 2012 Sep 5. Antivir Ther. 2012. PMID: 22948263

10

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.

Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group. Mandorfer M, et al. Among authors: ferlitsch a. AIDS. 2013 Jan 14;27(2):227-32. doi: 10.1097/QAD.0b013e32835aa161. AIDS. 2013. PMID: 23238552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters